Transmission of SAEs. Company will transmit to Merck all serious adverse events (“SAEs”) as follows: 5.2.1. For drug-related fatal and life-threatening SAEs, Company will send a processed case (on a CIOMS-1 form in English) within [*****] calendar days after receipt by Company of such SAEs. 5.2.2. For all other SAEs, including non-drug-related fatal and life-threatening SAEs, Company will send a processed case (on a CIOMS-1 form in English) within [*****] calendar days after receipt by Company of such SAEs.
Appears in 2 contracts
Samples: Clinical Trial Collaboration and Supply Agreement (ONCOSEC MEDICAL Inc), Clinical Trial Collaboration and Supply Agreement (ONCOSEC MEDICAL Inc)
Transmission of SAEs. Company will transmit to Merck all serious adverse events (“SAEs”) as follows:
5.2.1. For drug-related fatal and life-threatening SAEs, Company will send a processed case (on a CIOMS-1 form in English) within [*****] * calendar days after receipt by Company of such SAEs.
5.2.2. For all other SAEs, including non-drug-related fatal and life-threatening SAEs, Company will send a processed case (on a CIOMS-1 form in English) within [*****] * calendar days after receipt by Company of such SAEs.
Appears in 1 contract
Samples: Clinical Trial Collaboration and Supply Agreement (IMMUTEP LTD)
Transmission of SAEs. Company will transmit to Merck all serious adverse events (“SAEs”) as follows:
5.2.1. 5.2.1 For drug-related fatal and life-threatening SAEs, Company will send a processed case (on a CIOMS-1 form in English) within [* (*****] ) calendar days after receipt by Company of such SAEs.
5.2.2. 5.2.2 For all other SAEs, including non-drug-related fatal and life-threatening SAEs, Company will send a processed case (on a CIOMS-1 form in English) within [* (*****] ) calendar days after receipt by Company of such SAEs.
Appears in 1 contract
Samples: Clinical Trial Collaboration and Supply Agreement (ONCOSEC MEDICAL Inc)
